07/22/22 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/07/22 |
NCI |
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
06/05/23 |
NCI |
Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities |
Link |
NIH NOSI |
Application due: 10/10/26 |
08/02/22 |
NCI |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
04/01/22 |
NCI |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
03/11/24 |
NCI |
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
03/24/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
08/06/21 |
NCI |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Application due: 06/14/24 |
07/08/22 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
03/08/23 |
NCI |
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/17/24 |
11/28/20 |
NCI |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NCI |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments |
Link |
NIH NOSI |
Application due: 05/08/24 |
06/17/22 |
NCI |
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 05/17/24 |
04/01/22 |
NCI |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/02/22 |
NCI |
Biology of Bladder Cancer (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/04/22 |
NCI |
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings |
Link |
NIH NOSI |
Application due: 11/18/25 |
12/13/23 |
NCI |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 04/01/24 |
01/17/24 |
NCI |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NIH NOSI |
Application due: 07/02/25 |
07/22/22 |
NCI |
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
04/02/21 |
NCI |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/18/24 |
11/12/23 |
NCI |
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments |
Link |
NIH NOSI |
Application due: 05/08/24 |
07/22/22 |
NCI |
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
06/26/23 |
NCI |
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies |
Link |
NIH NOSI |
Application due: 09/08/26 |
07/15/22 |
NCI |
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates |
12/20/22 |
NCI |
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
09/10/21 |
NCI |
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute's Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional) |
Link |
NIH NOSI |
Application due: 09/25/24 |
09/18/20 |
NCI |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 - Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Administrative supplements to understand effects of within-group heterogeneity on cancer control outcomes in underrepresented populations |
Link |
NIH NOSI |
Application due: 04/30/24 |
04/10/23 |
NCI |
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/13/24 |
07/22/22 |
NCI |
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
08/16/22 |
NCI |
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 07/29/24 |
09/24/20 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk |
Link |
NIH NOSI |
Application due: 05/09/26 |
12/13/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
07/15/22 |
NCI |
Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment |
Link |
NIH NOSI |
Application due: 10/09/24 |
04/01/22 |
NCI |
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
09/18/20 |
NCI |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 04/01/24 |
05/06/22 |
NCI |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 04/01/24 |
07/22/22 |
NCI |
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 05/01/25 |
08/04/22 |
NCI |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 07/01/24 |
08/02/22 |
NCI |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/01/22 |
NCI |
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) |
Link |
NIH |
Standard due dates apply |
08/02/22 |
NCI |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/30/23 |
NCI |
Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research |
Link |
NIH NOSI |
Application due: 07/31/27 |
08/02/22 |
NCI |
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
01/17/24 |
NCI |
Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease |
Link |
NIH NOSI |
Application due: 05/10/27 |
01/09/23 |
NCI |
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/21/22 |
NCI |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
06/05/23 |
NCI |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NIH NOSI |
Application due: 07/02/25 |
07/22/22 |
NCI |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) |
Linnk |
NIH |
Standard due dates apply |
02/04/22 |
NCI |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/11/20 |
NCI |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
10/04/23 |
NCI |
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk |
Link |
NIH NOSI |
Application due: 09/08/24 |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/16/22 |
NCI |
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 07/29/24 |
05/15/20 |
NCI |
Announcement of Availability to Investigators of Lutathera® (815530) For Clinical and Nonclinical Study Proposals |
Link |
NCI |
|
03/14/23 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
07/22/22 |
NCI |
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates |
12/13/23 |
NCI |
Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies |
Link |
NIH NOSI |
Application due: 01/08/27 |
07/22/22 |
NCI |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
03/08/23 |
NCI |
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments |
Link |
NIH NOSI |
Application due: 05/08/24 |
10/21/22 |
NCI |
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings |
Link |
NIH NOSI |
Application due: 11/18/25 |
12/13/23 |
NCI |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 05/01/25 |
05/06/22 |
NCI |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 04/01/24 |
12/13/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/02/22 |
NCI |
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/07/24 |
01/17/24 |
NCI |
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences |
Link |
NIH NOSI |
Application due: 05/08/29 |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
07/22/22 |
NCI |
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Standard due dates apply |